Suicide and Self-Harm Risk Assessment
A 22-year-old female university student in Al Ain, seen by you for six sessions of therapy for depression, arrives for her appointment calm and smiling. Towards the end she mentions that she has 'sorted everything out', has given her laptop to her sister, and has been reading online about overdose with paracetamol, which she has at home. She denies a plan when you ask directly, says she feels relieved, and insists she must leave now for a lecture. She is not on any medication, and her family do not know she is in therapy. What would you do?
What the panel is testing: The panel wants to see that you recognise high-risk warning signs despite a calm presentation and a denial, that you do not let her leave without a plan, and that you know when risk exceeds what a psychologist can manage alone and must be escalated to a psychiatrist or emergency service.
Show the answer outline
Knowledge: Sudden calm or relief in a depressed patient, giving away possessions, researching a specific method and having access to the means are recognised warning signs that may indicate a decision has been made, so her denial of a plan does not reassure me. I would weigh static factors such as any past self-harm, and dynamic factors such as hopelessness, recent losses, isolation, substance use and the secrecy around her therapy. Current guidance, including NICE NG225, warns against using risk scales or tools alone to predict suicide or to decide who receives care, because they have poor predictive value; the assessment should be a clinical, needs-based conversation. Paracetamol overdose is dangerous partly because people often feel well initially while liver injury develops, so if any ingestion has occurred, urgent medical assessment is needed regardless of how she looks. Protective factors such as her sister, her studies, religious beliefs about suicide and her engagement in therapy should be explored, but they do not cancel out acute warning signs. My overall judgement here would be imminent high risk until shown otherwise.
Management: I would not let her leave for the lecture; I would tell her calmly that I am worried about her safety and that this takes priority. I would ask directly and specifically whether she has already taken anything, when she plans to act, what she has stored and where, and whether she has written notes or said goodbyes. If there is any possibility of ingestion, or she cannot engage in safety planning, I would arrange immediate emergency assessment, accompanying her or ensuring she is escorted, and I would contact the on-call psychiatrist for urgent review, because medical treatment and any decision about admission are beyond a psychologist's role. If she engages and the psychiatrist's assessment agrees a community plan is safe, I would build a written collaborative safety plan with warning signs, internal coping strategies, people and places for distraction, people she can ask for help, professional and emergency contacts, and removal of the paracetamol and other means, ideally with a trusted person who can hold them. I would seek her consent to involve her sister or another supporter in means restriction. Follow-up would be within one or two days, with increased session frequency, a review of the treatment plan, and a discussion with her family physician or psychiatrist about whether depression needs medical treatment. I would document the warning signs, my judgement of risk, the actions taken and the reasoning for them.
Ethics and communication: Confidentiality has limits when there is serious risk to life, and I would explain to her that I may need to involve others to keep her safe, while involving her in the decision as far as possible. Federal Law No. 10 of 2019 on Mental Health provides for involuntary admission only where there is a mental disorder and serious risk, and that decision rests with the psychiatric service, so my role is to escalate promptly rather than to detain her myself. I would respect her wish to keep therapy from her family where safe, but I would not promise secrecy that could cost her life. Documentation should be contemporaneous and record who I contacted and why. I would also seek supervision afterwards, both for good practice and for my own wellbeing.
Likely panel follow-up questions
- Why does NICE advise against relying on risk assessment tools to predict suicide?
- She refuses to stay and walks towards the door. What exactly do you do?
- What are the components of the Stanley-Brown safety plan?
- How would you talk to her sister about means restriction without breaching more confidentiality than needed?
- What would change if she told you she had already taken twenty tablets two hours ago?
Pitfalls in this case
- Accepting her denial of a plan and letting her leave for the lecture
- Reading sudden calm as improvement rather than a warning sign
- Using a risk score as the basis for the decision
- Failing to escalate to a psychiatrist or emergency service when risk is imminent
- Promising absolute confidentiality, or poor documentation of the decision
Reference: NICE NG225 Self-harm: Assessment, Management and Preventing Recurrence (2022); Stanley B and Brown GK, Safety Planning Intervention: A Brief Intervention to Mitigate Suicide Risk, Cognitive and Behavioral Practice (2012); WHO mhGAP Intervention Guide, version 2.0 (2016); UAE Federal Law No. 10 of 2019 on Mental Health